��Ⱦ����ѧ�о���

Imoto Y, Matsui H, Ueda C, Nakajima E, and Hanaki H (2025) Inactivation Effects of Hypochlorous Acid, Chlorine Dioxide, and Ozone on Airborne SARS-CoV-2 and Influenza A Virus. Food Environ Virol 17, 9.

Watanabe Y, Haneda T, Kimishima A, Kuwae A, Suga T, Suzuki T, Iwabuchi Y, Honsho M, Honma S, Iwatsuki M, Matsui H, Hanaki H, Kanoh N, Abe A, Asami Y, and Omura S (2024) PurA is the main target of aurodox, a type III secretion system inhibitor. Proc Natl Acad Sci U S A 121, e2322363121.

Takemoto K, Nakayama R, Fujimoto K, Suzuki Y, Takarabe Y, Honsho M, Kitahara S, Noguchi Y, Matsui H, Hirose T, Asami Y, Hidaka J, Sunazuka T, and Hanaki H (2024) In vitro and in vivo activities of KSP-1007, a broad-spectrum inhibitor of serine- and metallo-beta-lactamases, in combination with meropenem against carbapenem-resistant Gram-negative bacteria. Antimicrob Agents Chemother 68, e0160223.

Taba K, Honsho M, Asami Y, Iwasaki H, Nonaka K, Watanabe Y, Iwatsuki M, Matsui H, Hanaki H, Teruya T, and Ishii T (2024) Synergistic effect of secondary metabolites isolated from Pestalotiopsis sp. FKR-0115 in overcoming beta-lactam resistance in MRSA. J Gen Appl Microbiol 69, 234-238.

Matsui H, Ueda C, Nakajima E, Takarabe Y, Yamaguchi Y, Suzuki Y, Endo H, Sugamata M, Imoto Y, and Hanaki H (2024) Fluctuation in SARS-CoV-2 Environmental Surface Contamination Levels in Homes Where Patients With COVID-19 Stayed for Recuperation. Cureus 16, 1.

Matsui H, Sugamata M, Endo H, Suzuki Y, Takarabe Y, Yamaguchi Y, Hokari R, Ishiyama A, Ueda C, Nakajima E, Takeuchi O, Ujihara A, Imoto Y, and Hanaki H (2024) SARS-CoV-2 Contamination on Healthy Individuals' Hands in Community Settings During the COVID-19 Pandemic. Cureus 16, e54919.

Kimishima A, Tsuruoka I, Tsutsumi H, Honsho M, Honma S, Matsui H, Sugamata M, Wasuwanich P, Inahashi Y, Hanaki H, and Asami Y (2024) A new tetronomycin analog, broad-spectrum and potent antibiotic against drug-resistant Gram-positive bacteria. Chem Biodivers 21, e202301834.

Kimishima A, Honsho M, Terai J, Wasuwanich P, Honma S, Matsui H, Hanaki H, and Asami Y (2024) Efflux pump inhibitor, phenylalanine-arginine beta-naphthylamide analog potentiates the activity of 5-O-mycaminosyltylonolide for multi-drug resistant Pseudomonas aeruginosa. J Antibiot (Tokyo) 77, 185-188.

Azami H, Watanabe Y, Sakai K, Nakahara H, Kojima H, Tokiwa T, Nonaka K, Noguchi Y, Nagano Y, Hirose T, Sunazuka T, Matsui H, Arima N, Abe K, Hanaki H, and Iwatsuki M (2024) Antifungal profile against Candida auris clinical isolates of tyroscherin and its new analog produced by the deep-sea-derived fungal strain Scedosporium apiospermum FKJ-0499. J Antibiot (Tokyo) 77, 156-162.

Uematsu T, Takano T, Matsui H, Kobayashi N, Omura S, and Hanaki H (2023) Prophylactic administration of ivermectin attenuates SARS-CoV-2 induced disease in a Syrian Hamster Model. J Antibiot (Tokyo) 76, 481-488.

Matsui H, Ueda C, Nakajima E, Suzuki Y, Endo H, Sugamata M, Takarabe Y, Yamaguchi Y, Honsho M, Hokari R, Ishiyama A, Imoto Y, and Hanaki H (2023) Assessment of environmental surface contamination with SARS-CoV-2 in concert halls and banquet rooms in Japan. J Infect Chemother 29, 604-609.

Matsui H, Suzuki Y, Nakayama S, Asakura T, Takeuchi O, Kusatsugu K, Ueda C, Nakajima E, Suzuki Y, Endo H, Sugamata M, Takarabe Y, Yamaguchi Y, Horie K, Kobayashi Y, Kuronuma S, Imoto Y, and Hanaki H (2024) Levels of environmental contamination with SARS-CoV-2 in hospital rooms and salivary viral loads of patients with coronavirus disease 2019. J Infect Chemother 30, 315-322.

Kimishima A, Tsuruoka I, Kanto H, Tsutsumi H, Arima N, Sakai K, Sugamata M, Matsui H, Watanabe Y, Iwatsuki M, Honsho M, Naher K, Inahashi Y, Hanaki H, and Asami Y (2023) Rediscovery of Tetronomycin as a Broad-Spectrum and Potent Antibiotic against Drug-Resistant Gram-Positive Bacteria. ACS Omega 8, 11556-11563.

Kimishima A, Negami S, Tsuruoka I, Tsutsumi H, Matsui H, Sugamata M, Kondo N, Honsho M, Sakai K, Honma S, Naher K, Watanabe Y, Iwatsuki M, Inahashi Y, Hanaki H, and Asami Y (2023) Re-evaluation and a Structure-Activity Relationship Study for the Selective Anti-anaerobic Bacterial Activity of Luminamicin toward Target Identification. ACS Infect Dis 9, 1602-1609.

Kimishima A, Matsui H, Sakai K, Honsho M, Honma S, Sugamata M, Kondo N, Maruyama S, Wasuwanich P, Naher K, Arima N, Abe K, Hanaki H, and Asami Y (2023) Overcoming Native Macrolide and Acquired Multidrug-Resistant Pseudomonas aeruginosa with Azithromycin and Polymyxin B Nonapeptide BPB Reports 6, 141-143.

Ikeda A, Ikegaya Y, Honsho M, Matsui H, Nonaka K, Ishii T, Asami Y, Hanaki H, Hirose T, and Sunazuka T (2023) A new selective inhibitor for IMP-1 metallo-beta-lactamase, 3Z,5E-octa-3,5-diene-1,3,4-tricarboxylic acid-3,4-anhydride Bioorg Med Chem 78, 117109.

Nakayama R, Inoue-Tsuda M, Matsui H, Ito T, and Hanaki H (2022) Classification of the metallo beta-lactamase subtype produced by the carbapenem-resistant Pseudomonas aeruginosa isolates in Japan. J Infect Chemother 28, 170-175.

Kikuchi Y, Matsui H, Asami Y, Kuwae A, Inahashi Y, Hanaki H, and Abe A (2022) Landscape of bla(NDM) genes in Enterobacteriaceae. J Antibiot (Tokyo) 75, 559-566.

Matsui H, Uchiyama J, Ogata M, Nasukawa T, Takemura-Uchiyama I, Kato SI, Murakami H, Higashide M, and Hanaki H (2021) Use of Recombinant Endolysin to Improve Accuracy of Group B Streptococcus Tests. Microbiol Spectr 9, e0007721.

Matsui H, Sugimura M, Inoue-Tsuda M, Iwabuchi K, and Hanaki H (2021) Development of an immunochromatographic test for the detection of Mycoplasma pneumoniae GroES antigen. J Microbiol Methods 191, 106359.

Kanaida M, Kimishima A, Eguchi S, Iwatsuki M, Watanabe Y, Honsho M, Hirose T, Noguchi Y, Nonaka K, Sennari G, Matsui H, Kaito C, Hanaki H, Asami Y, and Sunazuka T (2021) Total Syntheses and Chemical Biology Studies of Hymeglusin and Fusarilactone A, Novel Circumventors of beta-Lactam Drug Resistance in Methicillin-Resistant Staphylococcus aureus. ChemMedChem 16, 2106-2111.

Takayama Y, Sekizuka T, Matsui H, Adachi Y, Eda R, Nihonyanagi S, Wada T, Matsui M, Suzuki S, Takaso M, Kitasato H, Kuroda M, and Hanaki H (2020) Characterization of the IncFII-IncFIB(pB171) Plasmid Carrying bla NDM-5 in Escherichia coli ST405 Clinical Isolate in Japan. Infect Drug Resist 13, 561-566.

Matsui H, Higashide M, and Hanaki H (2020) Evaluation of a rapid immunochromatographic test for the detection of Candida species from oropharyngeal samples. J Microbiol Methods 179, 106090.

Lee J, Iwasaki T, Ohtani S, Matsui H, Nejima R, Mori Y, Kagaya F, Yagi A, Yoshimura A, Hanaki H, Aihara M, and Miyata K (2020) Benzalkonium Chloride Resistance in Staphylococcus epidermidis on the Ocular Surface of Glaucoma Patients Under Long-Term Administration of Eye Drops. Transl Vis Sci Technol 9, 9.

Watanabe S, Ohnishi T, Yuasa A, Kiyota H, Iwata S, Kaku M, Watanabe A, Sato J, Hanaki H, Manabe M, Suzuki T, Otsuka F, Aihara M, Iozumi K, Tamaki T, Funada Y, Shinozaki M, Kobayashi M, Okuda M, Kikyo G, Kikuchi K, Okada Y, Takeshima M, Kaneko O, Ogawa N, Ito R, Okuyama R, Shimada S, Shimizu T, Hatta N, Manabu M, Tsutsui K, Tanaka T, Miyachi Y, Asada H, Furukawa F, Kurokawa I, Iwatsuki K, Hide M, Muto M, Yamamoto O, Niihara H, Takagaki K, Kubota Y, Sayama K, Sano S, Furue M, Kanekura T. The first nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan. J Infect Chemother. 2017 Aug;23(8):503-511.

Sugawara A, Maruyama H, Shibusawa S, Matsui H, Hirose T, Tsutsui A, Froyman R, Ludwig C, Koebberling J, Hanaki H, Kleefeld G, Omura S, Sunazuka T. 5-O-Mycaminosyltylonolide antibacterial derivatives: design, synthesis and bioactivity. J Antibiot (Tokyo). 2017 Jul;70(8):878-887.

Yanagihara K, Watanabe A, Aoki N, Matsumoto T, Yoshida M, Sato J, Wakamura T, Sunakawa K, Kadota J, Kiyota H, Iwata S, Kaku M, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M, Takeuchi K, Takeda H, Ikeda H, Miki M, Nakanowatari S, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Morino E, Takasaki J, Mezaki K, Chonabayashi N, Tanaka C, Sugiura H, Goto H, Saraya T, Kurai D, Katono Y, Inose R, Niki Y, Takuma T, Kudo M, Ehara S, Sato Y, Tsukada H, Watabe N, Honma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M, Seki M, Hamaguchi S, Toyokawa M, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Nakamura T, Mikasa K, Kasahara K, Ui K, Fukuda S, Nakamura A, Morimura M, Yamashita M, Takesue Y, Wada Y, Sugimoto K, Kusano N, Nose M, Mihara E, Kuwabara M, Doi M, Watanabe Y, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Ota T, Fujita M, Honda J, Hiramatsu K, Aoki Y, Fukuoka M, Magarifuchi H, Nagasawa Z, Kaku N, Fujita J, Higa F, Tateyama M. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2012: General view of the pathogens' antibacterial susceptibility. J Infect Chemother. 2017 Jun 29. pii: S1341-321X(17)30133-2.

Takesue Y, Kusachi S, Mikamo H, Sato J, Watanabe A, Kiyota H, Iwata S, Kaku M, Hanaki H, Sumiyama Y, Kitagawa Y, Mizuguchi T, Ambo Y, Konosu M, Ishibashi K, Matsuda A, Hase K, Harihara Y, Okabayashi K, Seki S, Hara T, Matsui K, Matsuo Y, Kobayashi M, Kubo S, Uchiyama K, Shimizu J, Kawabata R, Ohge H, Akagi S, Oka M, Wakatsuki T, Suzuki K, Okamoto K, Yanagihara K. Antimicrobial susceptibility of pathogens isolated from surgical site infections in Japan: Comparison of data from nationwide surveillance studies conducted in 2010 and 2014-2015. J Infect Chemother. 2017 Jun;23(6):339-348.

Fukumoto A, Kim YP, Matsumoto A, Takahashi Y, Suzuki M, Onodera H, Tomoda H, Matsui H, Hanaki H, Iwatsuki M, Omura S, Shiomi K. Naphthacemycins, novel circumventors of ��-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. I. The taxonomy of the producing strain, and the fermentation, isolation and antibacterial activities. J Antibiot (Tokyo). 2017 May;70(5):562-567.

Fukumoto A, Kim YP, Iwatsuki M, Hirose T, Sunazuka T, Hanaki H, Omura S, Shiomi K. Naphthacemycins, novel circumventors of ��-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. II. Structure elucidation. J Antibiot (Tokyo). 2017 May;70(5):568-573.

Hirose T, Kojima Y, Matsui H, Hanaki H, Iwatsuki M, Shiomi K, Omura S, Sunazuka T. Total synthesis of (��)-naphthacemycin A(9), possessing both antibacterial activity against methicillin-resistant Staphylococcus aureus and circumventing effect of ��-lactam resistance. J Antibiot (Tokyo). 2017 May;70(5):574-581.

Takahashi S, Hamasuna R, Yasuda M, Ishikawa K, Hayami H, Uehara S, Yamamoto S, Minamitani S, Kadota J, Iwata S, Kaku M, Watanabe A, Sato J, Hanaki H, Masumori N, Kiyota H, Egawa S, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Wada K, Kobayashi K, Matsubara A, Matsumoto T, Eto M, Tatsugami K, Kuroiwa K, Ito K, Hosobe T, Hirayama H, Narita H, Yamaguchi T, Ito S, Sumii T, Kawai S, Kanokogi M, Kawano H, Chokyu H, Uno S, Monden K, Kaji S, Kawahara M, Takayama K, Ito M, Yoshioka M, Kano M, Konishi T, Kadena H, Nishi S, Nishimura H, Yamauchi T, Maeda S, Horie M, Ihara H, Matsumura M, Shirane T, Takeyama K, Akiyama K, Takahashi K, Ikuyama T, Inatomi H, Yoh M. Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan. J Infect Chemother. 2016 Sep;22(9):581-6. 27452428.

Suga T, Shiina M, Asami Y, Iwatsuki M, Yamamoto T, Nonaka K, Masuma R, Matsui H, Hanaki H, Iwamoto S, Onodera H, Shiomi K, Omura S. Paraphaeosphaeride D and berkleasmin F, new circumventors of arbekacin resistance in MRSA, produced by Paraphaeosphaeria sp. TR-022. J Antibiot (Tokyo). 2016 Aug;69(8):605-10.

Hirai J, Hagihara M, Kato H, Sakanashi D, Nishiyama N, Koizumi Y, Yamagishi Y, Suematsu H, Hanaki H, Mikamo H. Investigation on rifampicin administration from the standpoint of pharmacokinetics/pharmacodynamics in a neutropenic murine thigh infection model. J Infect Chemother. 2016 Jun;22(6):387-94.

Sugawara A, Shima H, Sueki A, Hirose T, Matsui H, Nakano H, Hanaki H, Akagawa KS, Omura S, Sunazuka T. Non-antibiotic 12-membered macrolides: design, synthesis and biological evaluation in a cigarette-smoking model. J Antibiot (Tokyo). 2016 Apr;69(4):319-26.

Okada T, Sato Y, Toyonaga Y, Hanaki H, Sunakawa K. Nationwide survey of Streptococcus pneumoniae drug resistance in the pediatric field in Japan. Pediatr Int. 2016 Mar;58(3):192-201.

Ishikawa K, Hamasuna R, Uehara S, Yasuda M, Yamamoto S, Hayami H, Takahashi S, Matsumoto T, Minamitani S, Kadota J, Iwata S, Kaku M, Watanabe A, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Deguchi T, Matsumoto M, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Wakeda H, Amemoto Y, Onodera S, Goto H, Komeda H, Yamashita M, Takenaka T, Fujimoto Y, Tsugawa M, Takahashi Y, Maeda H, Onishi H, Ishitoya S, Nishimura K, Mitsumori K, Ito T, Togo Y, Nakamura I, Ito N, Kanamaru S, Hirose T, Muranaka T, Yamada D, Ishihara S, Oka H, Inatomi H, Matsui T, Kobuke M, Kunishima Y, Kimura T, Ichikawa T, Kagara I, Matsukawa M, Takahashi K, Mita K, Kato M, Okumura K, Kawanishi H, Hashimura T, Aoyama T, Shigeta M, Koda S, Taguchi K, Matsuda Y. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases. J Infect Chemother. 2015 Sep;21(9):623-33.

Masaki K, Ishii M, Anraku M, Namkoong H, Miyakawa R, Nakajima T, Fukunaga K, Naoki K, Tasaka S, Soejima K, Sayama K, Sugita K, Iwata S, Cui L, Hanaki H, Hasegawa N, Betsuyaku T. Fatal Fulminant Pneumonia Caused by Methicillin-Sensitive Staphylococcus aureus Negative for Major High-Virulence Factors Following Influenza B Virus Infection. Am J Case Rep. 2015 Jul 14;16:454-8.

Suzuki K, Kurono Y, Ikeda K, Watanabe A, Iwamoto A, Totsuka K, Kaku M, Iwata S, Kadota J, Hanaki H. Nationwide surveillance of 6 otorhinolaryngological infectious diseases and antimicrobial susceptibility pattern in the isolated pathogens in Japan. J Infect Chemother. 2015 Jul;21(7):483-91.

Ikeda-Dantsuji Y, Hanaki H, Sakai F, Tomono K, Takesue Y, Honda J, Nonomiya Y, Suwabe A, Nagura O, Yanagihara K, Mikamo H, Fukuchi K, Kaku M, Kohno S, Yanagisawa C, Nakae T, Yoshida K, Niki Y. Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan. Kansenshogaku Zasshi. 2015 Jul;Suppl 13:8-14.

Yanagihara K, Kadota J, Aoki N, Matsumoto T, Yoshida M, Yagisawa M, Oguri T, Sato J, Ogasawara K, Wakamura T, Sunakawa K, Watanabe A, Iwata S, Kaku M, Hanaki H, Ohsaki Y, Watari T, Toyoshima E, Takeuchi K, Shiokoshi M, Takeda H, Miki M, Kumagai T, Nakanowatari S, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Kobayashi N, Takasaki J, Mezaki K, Konosaki H, Aoki Y, Yamamoto Y, Shoji M, Goto H, Saraya T, Kurai D, Okazaki M, Niki Y, Yoshida K, Kawana A, Saionji K, Fujikura Y, Miyazawa N, Kudo M, Sato Y, Yamamoto M, Yoshida T, Nakamura M, Tsukada H, Imai Y, Tsukada A, Kawasaki S, Honma Y, Yamamoto T, Ban N, Mikamo H, Sawamura H, Miyara T, Toda H, Sato K, Nakamura T, Fujikawa Y, Mitsuno N, Mikasa K, Kasahara K, Sano R, Sugimoto K, Asari S, Nishi I, Toyokawa M, Miyashita N, Koguchi Y, Kusano N, Mihara E, Kuwabara M, Watanabe Y, Kawasaki Y, Takeda K, Tokuyasu H, Masui K, Negayama K, Hiramatsu K, Aoki Y, Fukuoka M, Magarifuchi H, Nagasawa Z, Suga M, Muranaka H, Morinaga Y, Honda J, Fujita M. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2010: General view of the pathogens' antibacterial susceptibility. J Infect Chemother. 2015 Jun;21(6):410-20.

Hamasuna R, Yasuda M, Ishikawa K, Uehara S, Hayami H, Takahashi S, Matsumoto T, Yamamoto S, Minamitani S, Watanabe A, Iwata S, Kaku M, Kadota J, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Naito S, Kuroiwa K, Hirayama H, Narita H, Hosobe T, Ito S, Ito K, Kawai S, Ito M, Chokyu H, Matsumura M, Yoshioka M, Uno S, Monden K, Takayama K, Kaji S, Kawahara M, Sumii T, Kadena H, Yamaguchi T, Maeda S, Nishi S, Nishimura H, Shirane T, Yoh M, Akiyama K, Imai T, Kano M. The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013. J Infect Chemother. 2015 May;21(5):340-5.

Baba H, Sato Y, Toyonaga Y, Hanaki H, Sunakawa K. Nationwide survey of the development of drug resistance in the pediatric field in 2007, 2010, and 2012: drug sensitivity of Haemophilus influenzae serotype b strain in Japan. J Infect Chemother. 2015 Apr;21(4):277-83.

Shiro H, Sato Y, Toyonaga Y, Hanaki H, Sunakawa K. Nationwide survey of the development of drug resistance in the pediatric field in 2000-2001, 2004, 2007, 2010, and 2012: evaluation of the changes in drug sensitivity of Haemophilus influenzae and patients' background factors. J Infect Chemother. 2015 Apr;21(4):247-56.

Iwata S, Sato Y, Toyonaga Y, Hanaki H, Sunakawa K. Genetic analysis of a pediatric clinical isolate of Moraxella catarrhalis with resistance to macrolides and quinolones. J Infect Chemother. 2015 Apr;21(4):308-1

Nihonyanagi S, Sunakawa K, Cui L, Masaki T, Wada T, Hoshiyama T, Nakamura M, Takayama Y, Kanoh Y, Ogawa A, Shichiri M, Hanaki H. A very rare case of primary meningococcal arthritis in an adult male. Clin Case Rep. 2015 Feb;3(2):76-80.

Shoji H, Maeda M, Shirakura T, Takuma T, Hanaki H, Niki Y. Changes in the Distribution of Capsular Serotypes of Streptococcus pneumoniae Isolated from Adult Respiratory Specimens in Japan. Intern Med. 2015;54(11):1337-41.

Uchida R, Hanaki H, Matsui H, Hamamoto H, Sekimizu K, Iwatsuki M, Kim YP, Tomoda H. In vitro and in vivo anti-MRSA activities of nosokomycins. Drug Discov Ther. 2014 Dec;8(6):249-54.

Hanaki H, Cui L, Ikeda-Dantsuji Y, Nakae T, Honda J, Yanagihara K, Takesue Y, Matsumoto T, Sunakawa K, Kaku M, Tomono K, Fukuchi K, Kusachi S, Mikamo H, Takata T, Otsuka Y, Nagura O, Fujitani S, Aoki Y, Yamaguchi Y, Tateda K, Kadota J, Kohno S, Niki Y. Antibiotic susceptibility survey of blood-borne MRSA isolates in Japan from 2008 through 2011. J Infect Chemother. 2014 Sep;20(9):527-34.

Shoji H, Shirakura T, Fukuchi K, Takuma T, Hanaki H, Tanaka K, Niki Y. A molecular analysis of quinolone-resistant Haemophilus influenzae: validation of the mutations in Quinolone Resistance-Determining Regions. J Infect Chemother. 2014 Apr;20(4):250-5.

Uchiyama J, Takemura-Uchiyama I, Kato S, Sato M, Ujihara T, Matsui H, Hanaki H, Daibata M, Matsuzaki S. In silico analysis of AHJD-like viruses, Staphylococcus aureus phages S24-1 and S13', and study of phage S24-1 adsorption. Microbiologyopen. 2014 Apr;3(2):257-70.

Takata K, Iwatsuki M, Yamamoto T, Shirahata T, Nonaka K, Masuma R, Hayakawa Y, Hanaki H, Kobayashi Y, Petersson GA, Omura S, Shiomi K. Aogacillins A and B produced by Simplicillium sp. FKI-5985: new circumventors of arbekacin resistance in MRSA. Org Lett. 2013 Sep 20;15(18):4678-81.

Matsui H, Kimura J, Higashide M, Takeuchi Y, Okue K, Cui L, Nakae T, Sunakawa K, Hanaki H. Immunochromatographic detection of the group B streptococcus antigen from enrichment cultures. Clin Vaccine Immunol. 2013 Sep;20(9):1381-7.

Hamasuna R, Yasuda M, Ishikawa K, Uehara S, Takahashi S, Hayami H, Yamamoto S, Matsumoto T, Minamitani S, Watanabe A, Iwamoto A, Totsuka K, Kadota J, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Naito S, Tatsugami K, Ito S, Narita H, Kanokogi M, Sumii T, Ito K, Hosobe T, Kawai S, Kawano H, Takayama K, Yamaguchi T, Endo K, Yamauchi T, Maeda S, Yoh M, Horie M, Ito M, Chokyu H, Ihara H, Akiyama K, Uno S, Monden K, Kaji S, Nishimura H, Kawahara M, Sato T, Konishi T, Nishi S, Ishihara S, Yoshioka M. Nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan. J Infect Chemother. 2013 Aug;19(4):571-8.

Hayami H, Takahashi S, Ishikawa K, Yasuda M, Yamamoto S, Uehara S, Hamasuna R, Matsumoto T, Minamitani S, Watanabe A, Iwamoto A, Totsuka K, Kadota J, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Naito S, Tatsugami K, Yamaguchi T, Ito S, Kanokogi M, Narita H, Kawano H, Hosobe T, Takayama K, Sumii T, Fujii A, Sato T, Yamauchi T, Izumitani M, Chokyu H, Ihara H, Akiyama K, Yoshioka M, Uno S, Monden K, Kano M, Kaji S, Kawai S, Ito K, Inatomi H, Nishimura H, Ikuyama T, Nishi S, Takahashi K, Kawano Y, Ishihara S, Tsuneyoshi K, Matsushita S, Yamane T, Hirose T, Fujihiro S, Endo K, Oka Y, Takeyama K, Kimura T, Uemura T. Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus. J Infect Chemother. 2013 Jun;19(3):393-403.

Tajima T, Sato Y, Toyonaga Y, Hanaki H, Sunakawa K. Nationwide survey of the development of drug-resistant pathogens in the pediatric field in 2007 and 2010: drug sensitivity of Streptococcus pneumoniae in Japan (second report). J Infect Chemother. 2013 Jun;19(3):510-6.

Hoshino T, Sato Y, Toyonaga Y, Hanaki H, Sunakawa K; Drug-Resistant Pathogen Surveillance Group in Pediatric Infectious Disease. Nationwide survey of the development of drug resistance in the pediatric field in 2007 and 2010: drug sensitivity of Haemophilus influenzae in Japan (second report). J Infect Chemother. 2013 Jun;19(3):495-503.

Matsumoto T, Hanaki H, Kimura T, Nemoto M, Higashihara M, Yokota H, Oda S, Akiyama N, Miyao N, Yoshida M, Yukioka T, Soma K, Ohyashiki K, Suzuki Y, Arai T, Ikegami K, Ichiwata T, Otsuka Y, Kobayashi M, Totsuka K, Sunakawa K; ABK Dose Finding Study Group. Clinical efficacy and safety of arbekacin sulfate in patients with MRSA sepsis or pneumonia: a multi-institutional study. J Infect Chemother. 2013 Feb;19(1):128-37.

Tsutsui A, Hirose T, Ishiyama A, Iwatsuki M, Yokota A, Maruyama H, Matsui H, Otoguro K, Hanaki H, Omura S, Sunazuka T. Antimalarial C-9 oxime derivatives from desmycosin, produced by click chemistry. J Antibiot (Tokyo). 2013 Mar;66(3):191-4.

Tsutsui A, Hirose T, Ishiyama A, Iwatsuki M, Yokota A, Maruyama H, Matsui H, Otoguro K, Hanaki H, Omura S, Sunazuka T. : Antimalarial C-9 oxime derivatives from desmycosin, produced by click chemistry.�� J Antibiot (Tokyo). 2012 12. doi: 10.1038/ja.2012.113. [Epub ahead of print].

Matsumoto T, Hanaki H, Kimura T, Nemoto M, Higashihara M, Yokota H, Oda S, Akiyama N, Miyao N, Yoshida M, Yukioka T, Soma K, Ohyashiki K, Suzuki Y, Arai T, Ikegami K, Ichiwata T, Otsuka Y, Kobayashi M, Totsuka K, Sunakawa K. ; ABK Dose Finding Study Group.�� Clinical efficacy and safety of arbekacin sulfate in patients with MRSA sepsis or pneumonia: a multi-institutional study.��J Infect Chemother. 2012 Dec 22. [Epub ahead of print].

Matsumoto T, Hanaki H, Kimura T, Nemoto M, Higashihara M, Yokota H, Oda S, Akiyama N, Miyao N, Yoshida M, Yukioka T, Soma K, Ohyashiki K, Suzuki Y, Arai T, Ikegami K, Ichiwata T, Otsuka Y, Kobayashi M, Totsuka K, Sunakawa K. : ABK Dose Finding Study Group. Clinical efficacy and safety of arbekacin sulfate in patients with MRSA sepsis or pneumonia: a multi-institutional study. J Infect Chemother. 2012 Dec 22. [Epub ahead of print].

Tsutsui A, Hirose T, Ishiyama A, Iwatsuki M, Yokota A, Maruyama H, Matsui H, Otoguro K, Hanaki H, Omura S, Sunazuka T. : Antimalarial C-9 oxime derivatives from desmycosin, produced by click chemistry. J Antibiot (Tokyo). 2012 Dec 12. doi: 10.1038/ja.2012.113. [Epub ahead of print].

Takesue Y, Watanabe A, Hanaki H, Kusachi S, Matsumoto T, Iwamoto A, Totsuka K, Sunakawa K, Yagisawa M, Sato J, Oguri T, Nakanishi K, Sumiyama Y, Kitagawa Y, Wakabayashi G, Koyama I, Yanaga K, Konishi T, Fukushima R, Seki S, Imai S, Shintani T, Tsukada H, Tsukada K, Omura K, Mikamo H, Takeyama H, Kusunoki M, Kubo S, Shimizu J, Hirai T, Ohge H, Kadowaki A, Okamoto K, Yanagihara K. : Nationwide surveillance of antimicrobial susceptibility patterns of pathogens isolated from surgical site infections (SSI) in Japan. J Infect Chemother. 2012 Dec;18(6):816-26.

Suga T, Ishii T, Iwatsuki M, Yamamoto T, Nonaka K, Masuma R, Matsui H, Hanaki H, Omura S, Shiomi K. : Aranorosin circumvents arbekacin-resistance in MRSA by inhibiting the bifunctional enzyme AAC(6')/APH(2��). J Antibiot (Tokyo). 2012 Oct;65(10):527-9.

Yuriko Hirao, Yurika Ikeda-Dantsuji, Hidehito Matsui, Masaki Yoshida, Seiji Hori, Keisuke Sunakawa , Taiji Nakae, and Hideaki Hanaki. Low level ß-lactamase production in methicillin-resistant <em>Staphylococcus aureus </em>with ß-lactam-antibiotic-induced vancomycin resistance. BMC Microbiol. 2012 May 8;12(1):69.

Watanabe A, Yanagihara K, Matsumoto T, Kohno S, Aoki N, Oguri T, Sato J, Muratani T, Yagisawa M, Ogasawara K, Koashi N, Kozuki T, Komoto A, Takahashi Y, Tsuji T, Terada M, Nakanishi K, Hattori R, Hirako Y, Maruo A, Minamitani S, Morita K, Wakamura T, Sunakawa K, Hanaki H, Ohsaki Y, Honda Y, Sasaoka S, Takeda H, Ikeda H, Sugai A, Miki M, Nakanowatari S, Takahashi H, Utagawa M, Kobayashi N, Takasaki J, Konosaki H, Aoki Y, Shoji M, Goto H, Saraya T, Kurai D, Okazaki M, Kobayashi Y, Katono Y, Kawana A, Saionji K, Miyazawa N, Sato Y, Watanuki Y, Kudo M, Ehara S, Tsukada H, Imai Y, Watabe N, Aso S, Honma Y, Mikamo H, Yamagishi Y, Takesue Y, Wada Y, Nakamura T, Mitsuno N, Mikasa K, Kasahara K, Uno K, Sano R, Miyashita N, Kurokawa Y, Takaya M, Kuwabara M, Watanabe Y, Doi M, Shimizu S, Negayama K, Kadota J, Hiramatsu K, Morinaga Y, Honda J, Fujita M, Iwata S, Iwamoto A, Ezaki T, Onodera S, Kusachi S, Tateda K, Tanaka M, Totsuka K, Niki Y, Matsumoto T. : Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: general view of the pathogens' antibacterial susceptibility. J Infect Chemother. 2012 Oct;18(5):609-20.

Yurika Ikeda-Dantsuji, Taiji Nakae, Koichi Ariyoshi, Hidekazu Mizuno, Hidehiko Moriyama, Osanori Nagura, Akira Suwabe, Kunihiko Fukuchi, Junichi Honda, Mitsuo Kaku, Shigeru Kohno, Hiroshige Mikamo, Yoshihito Niki, Yoshio Takesue, Kazunori Tomono, Katsunori Yanagihara, and Hideaki Hanaki. : Limited detectability of linezolid-resistant <em>Staphylococcus aureus </em>by the Etest method and its improvement using enriched media. J Med Microbiol. 2012 Jul;61(Pt 7):998-1002.

Nihonyanagi S, Adachi Y, Onuki T, Nakazaki N, Hirata Y, Fujiki K, Takayama Y, Kanoh Y, Bandoh Y, Dantsuji Y, Hanaki H, Sunakawa K. : Emergence of linezolid-resistant <em>Enterococcus faecalis  </em>strains from two inpatients in a pediatric ward. Kansenshogaku Zasshi. 2012 Sep;86(5):555-62. Japanese.

Longzhu Cui, Hui-min Neoh, Akira Iwamoto, and Keiichi Hiramatsu. : Coordinated phenotype switching with large-scale chromosome flip-flop inversion observed in bacteria. PNAS. 2012 June 19;109(25): E1647-1656.

Masato Iwatsuki, Toshiya Ishimori, Tsuyoshi Yamamoto, Keiko Takata, Mihoko Mori, Kenichi Nonaka, Rokuro Masuma, Yoichi Hayakawa, Hideaki Hanaki, Kazuro Shiomi , Satoshi _Omura : a. Biverlactones AeD, new circumventors of arbekacin resistance in MRSA, produced by <em>Penicillium </em>sp. FKI-4429. Tetrahedron. 2011, 67:6644-6648.

Niki Y, Hanaki H, Matsumoto T, Yagisawa M, Kohno S, Aoki N, Watanabe A, Sato J, Hattori R, Koashi N, Terada M, Kozuki T, Maruo A, Morita K, Ogasawara K, Takahashi Y, Matsuda K, Nakanishi K, Sunakawa K, Takeuchi K, Fujimura S, Takeda H, Ikeda H, Sato N, Niitsuma K, Saito M, Koshiba S, Kaneko M, Miki M, Nakanowatari S, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Aoki Y, Chonabayashi N, Sugiura H, Ichioka M, Goto H, Kurai D, Saraya T, Okazaki M, Yoshida K, Yoshida T, Tsukada H, Imai Y, Honma Y, Yamamoto T, Kawai A, Mikamo H, Takesue Y, Wada Y, Miyara T, Toda H, Mitsuno N, Fujikawa Y, Nakajima H, Kubo S, Ohta Y, Mikasa K, Kasahara K, Koizumi A, Sano R, Yagi S, Takaya M, Kurokawa Y, Kusano N, Mihara E, Nose M, Kuwabara M, Fujiue Y, Ishimaru T, Matsubara N, Kawasaki Y, Tokuyasu H, Masui K, Kido M, Ota T, Honda J, Kadota J, Hiramatsu K, Aoki Y, Nagasawa Z, Yanagihara K, Fujita J, Tateyama M, Totsuka K. : Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2008: general view of the pathogens' antibacterial susceptibility. J Infect Chemother. 2011 Mar 17(4):510-23.

Ikeda-Dantsuji Y, Hanaki H, Nakae T, Takesue Y, Tomono K, Honda J, Yanagihara K, Mikamo H, Fukuchi K, Kaku M, Kohno S, Niki Y. : Emergence of linezolid-resistant mutants in the susceptible cell population of methicillin-resistant <em>Staphylococcus aureus</em>. Antimicrob Agents Chemother. 2011 May,55(5):2466-8.

Ishikawa K, Matsumoto T, Yasuda M, Uehara S, Muratani T, Yagisawa M, Sato J, Niki Y, Totsuka K, Sunakawa K, Hanaki H, Hattori R, Terada M, Kozuki T, Maruo A, Morita K, Ogasawara K, Takahashi Y, Matsuda K, Hirose T, Miyao N, Hayashi T, Takeyama K, Kiyota H, Tomita M, Yusu H, Koide H, Kimura S, Yanaoka M, Sato H, Ito T, Deguchi T, Fujimoto Y, Komeda H, Asano Y, Takahashi Y, Ishihara S, Arakawa S, Nakano Y, Tanaka K, Fujisawa M, Matsui T, Fujii A, Yamamoto S, Nojima M, Higuchi Y, Ueda Y, Kanamaru S, Monden K, Tsushima T, Seno Y, Tsugawa M, Takenaka T, Hamasuna R, Fujimoto N, Sho T, Takahashi K, Inatomi H, Takahashi N, Ikei Y, Hayami H, Yamane T, Nakagawa M, Kariya S, Arima T. : The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy. J Infect Chemother2011 Feb;17(1):126-38.

Matsui H, Hanaki H, Inoue M, Akama H, Nakae T, Sunakawa K, Omura S. : Development of an Immunochromatographic Strip for Simple Detection of Penicillin Binding Protein 2'. Clin Vaccine Immunol. 2011 Feb;18(2):248-53.

Sakai F, Hanaki H, Barada K, Hirao Y, Inamatsu T, Nakae T, Sunakawa K. : A 25-year trace of methicillin-resistant <em>Staphylococcus aureus </em>dissemination in a geriatric hospital in Japan. Int J Gen Med. 2010 Dec 9;3:399-405.

Sakai F, Hanaki H, Ikeda-Dantsuji Y, Hirao Y, Nonoyama M, Iwata S, Sato Y, Akita H, Nakae T, Sunakawa K. : Trends in empirical chemotherapy of bacterial meningitis in children aged more than 4 months in Japan: a survey from 1997 through 2008.��J Infect Chemother. 2010 Sep 29.

Kobayashi Y, Ichioka M, Hirose T, Nagai K, Matsumoto A, Matsui H, Hanaki H, Masuma R, Takahashi Y,��Omura S, Sunazuka T. :Bottromycin derivatives: efficient chemical modifications of the ester moiety and evaluation of anti-MRSA and anti-VRE activities. Bioorg Med Chem Lett. 2010 Oct 15;20(20):6116-20.

Ikeda-Dantsuji Y, Hanaki H, Sakai F, Tomono K, Takesue Y, Honda J, Nonomiya Y, Suwabe A, Nagura O, Yanagihara K, Mikamo H, Fukuchi K, Kaku M, Kohno S, Yanagisawa C, Nakae T, Yoshida K, Niki Y. : Linezolid-resistant <em>Staphylococcus aureus </em>isolated from 2006 through 2008 at six hospitals in Japan. J Infect Chemother. 2011 Feb;17(1):45-51.

Ikeda S, Hanaki H, Yanagisawa C, Ikeda-Dantsuji Y, Matsui H, Iwatsuki M, Shiomi K, Nakae T, Sunakawa K, Omura S. : Identification of the active component that induces vancomycin resistance in MRSA. J Antibiot (Tokyo)2010 Sep;63(9):533-8.

Ishihara K, Shimokubo N, Sakagami A, Ueno H, Muramatsu Y, Kadosawa T, Yanagisawa C, Hanaki H, Nakajima C, Suzuki Y, Tamura Y. : Occurrence and molecular characteristics of methicillin-resistant <em>Staphylococcus aureus </em>and methicillin-resistant <em>Staphylococcus pseudintermedius </em>in an academic veterinary hospital. Appl Environ Microbiol2010 Aug;76(15):5165-74.

Higuchi W, Mimura S, Kurosawa Y, Takano T, Iwao Y, Yabe S, Razvina O, Nishiyama A, Ikeda-Dantsuji Y, Sakai F, Hanaki H, Yamamoto T. : Emergence of the community-acquired methicillin-resistant <em>Staphylococcus aureus </em>USA300 clone in a Japanese child, demonstrating multiple divergent strains in Japan. J Infect Chemother2010 Aug;16(4):292-7.

Higuchi W, Hung WC, Takano T, Iwao Y, Ozaki K, Isobe H, Teng LJ, Shimazaki T, Honda A, Higashide M, Hanaki H, Yamamoto T. : Molecular characteristics of the Taiwanese multiple drug-resistant ST59 clone of Panton-Valentine leucocidin-positive community-acquired methicillin-resistant <em>Staphylococcus aureus </em>from pediatric cellulitis.�� J Infect Chemother. 2010. Apr;16(2):144-9.